Fredun Pharmaceuticals Ltd Q3 FY2023-2024 Results: Summary

Revenue
₹87.01Cr
Net Profits
₹4.22Cr
Net Profit Margins
4.85%

Highlights

Revenue:

Fredun Pharmaceuticals Ltd’s revenue jumped 11.61% since last year same period to ₹87.01Cr in the Q3 2023-2024. On a quarterly growth basis, Fredun Pharmaceuticals Ltd has generated 6.12% jump in its revenue since last 3-months.

Net Profits:

Fredun Pharmaceuticals Ltd’s net profit jumped 21.97% since last year same period to ₹4.22Cr in the Q3 2023-2024. On a quarterly growth basis, Fredun Pharmaceuticals Ltd has generated 7.11% jump in its net profits since last 3-months.

Net Profit Margins:

Fredun Pharmaceuticals Ltd’s net profit margin jumped 9.28% since last year same period to 4.85% in the Q3 2023-2024. On a quarterly growth basis, Fredun Pharmaceuticals Ltd has generated 0.93% jump in its net profit margins since last 3-months.

FAQs

The revenue for Fredun Pharmaceuticals Ltd in the Q3 results 2023 was ₹87.01Cr.

The net profit for Fredun Pharmaceuticals Ltd in the Q3 results 2023 was ₹4.22Cr.

The net profit margin for Fredun Pharmaceuticals Ltd in the Q3 results 2023 was 4.85%.

The revenue for Fredun Pharmaceuticals Ltd in the Q3 results 2022 was ₹77.96Cr.

The net profit for Fredun Pharmaceuticals Ltd in the Q3 results 2022 was ₹3.46Cr.

The net profit margin for Fredun Pharmaceuticals Ltd in the Q3 results 2022 was 4.44%.